NASDAQ
GreenLight Biosciences Holdings (GRNA) has a free cash flow growth of -15.88% as of Friday, May 29, 2026. This represents a 56.24% increase compared to its 12-month average of -36.29%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.